跳到正文

Ra Capital Management, L.P. 13F 持仓 · 2026年Q2

Ra Capital Management 在 2026年Q2(报告期截至 2026-06-30)的 SEC 13F 申报中报告了 84 只证券,申报市值合计 115.08 亿美元。前几大持仓:ASND(23.83%)、PBLS(6.88%)、RYTM(6.43%)。本季前 25 大持仓中:新建仓 5 只、增持 2 只、减持 3 只。

排名代码公司市值占组合股数变动
1ASNDASCENDIS PHARMA A/S$2.74B23.83%10.3M新建仓
2PBLSPARABILIS MEDICINES INC$791.9M6.88%28.9M新建仓
3RYTMRHYTHM PHARMACEUTICALS INC$740.2M6.43%6.7M持平
4PCVXVAXCYTE INC$667.0M5.80%11.5M持平
5SIONSIONNA THERAPEUTICS INC$435.7M3.79%9.9M持平
6TYRATYRA BIOSCIENCES INC$389.6M3.39%12.2M持平
7EWTXEDGEWISE THERAPEUTICS INC$341.0M2.96%8.4M减持
8NAMSNEWAMSTERDAM PHARMA CO NV$323.7M2.81%9.6M持平
9COAGHEMAB THERAPEUTICS HOLDINGS$286.8M2.49%7.8M新建仓
10SEPNSEPTERNA INC$234.3M2.04%7.0M持平
11BCAXBICARA THERAPEUTICS INC$215.4M1.87%7.3M持平
12MLYSMINERALYS THERAPEUTICS INC$207.6M1.80%7.7M持平
13GHRSGH RESEARCH PLC$205.3M1.78%7.6M减持
14IRONDISC MEDICINE INC$179.2M1.56%2.5M持平
15SGPSPYGLASS PHARMA INC$178.6M1.55%8.0M持平
16ARTVARTIVA BIOTHERAPEUTICS INC$174.2M1.51%18.0M增持
17JANXJANUX THERAPEUTICS INC$171.9M1.49%11.2M持平
18TSHATAYSHA GENE THERAPIES INC$160.4M1.39%23.6M持平
19BCRXBIOCRYST PHARMACEUTICALS INC$158.3M1.38%15.8M持平
20WVEWAVE LIFE SCIENCES LTD$156.7M1.36%27.0M持平
21NUVLNUVALENT INC-A$153.9M1.34%1.2M减持
22ABVXABIVAX SA-ADR$150.9M1.31%1.1M新建仓
23ORKAORUKA THERAPEUTICS INC$148.0M1.29%1.6M新建仓
24CLYMCLIMB BIO INC$147.4M1.28%11.3M持平
25SLDBSOLID BIOSCIENCES INC$120.2M1.04%12.0M增持

来源:SEC 13F 申报文件 · 截至 2026-06-30

本期 13F-HR 中的全部持仓,以及相对上季度的变化。

13F 持仓,最新季度

来源SEC EDGAR13F-HR